Trial of low molecular weight heparin in the treatment of viper bites

Journal of Association of Physicians of India

Volumn 55, Issue MAY, 2007, Pages 338-342

  Paul, V ^a   Pudoor, A ^a   Earali, Jerry ^a   John, Binu ^a   Kumar CS, Anil ^a   Anthony, T ^a  

^a Jubilee Mission Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; VENOM ANTISERUM;

ADULT; ANIMAL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; MALE; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SNAKE; SNAKEBITE; TREATMENT OUTCOME;

ADULT; ANIMALS; ANTICOAGULANTS; ANTIVENINS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; PROTHROMBIN TIME; SNAKE BITES; TREATMENT OUTCOME; VIPERIDAE;

EID: 34247884400     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Warrel DA, Pope HM, Prentice CR. Disseminated Intra Vascular Coagulation Caused by the Carpet Viper (Echis Carinatus) Trial of Heparin B. J Haematology 1976;33:335-42.
2. Myint L, Tin Nu S, Myint Aye M, Than T, Thein T, Tun P. Heparin Therapy In Russell Viper Bite Victims With Impending DIC (Controlled Trial). South East Asian J Tro Med Public Health 1989;2:271-7.
3. Weiss HJ, Philips LI, Hopewell WS, Philips G, Christy NP, Nitti JF. Heparin Therapy in a Patient Bitten by a Saw Scaled Viper (Echis Carinatus). A Snake Whose Venom Activates Prothrombin. Am J Med 1973;54:653-62.
4. Asakura H, Jokaji H, Saito M, et al. The Course of Disseminated Intravascular Coagulation Is Predicted By Changes. In Thrombin-Antithrombin III Complex Levels- Is There Any Difference Between Treatment with Standard Heparin or Low Molecular Weight Heparin? Blood Coagul Fibrinolysis 1991;2:623-7.
5. Paul V, Prahlad KA, Earali J, Francis S, Lewis F. Trial of Heparin in Viper Bites. J Assoc Physicians India 2003;51:163-6.
6. Paul V, Pratibha S, Prahlad KA, Earali J, Francis S, Lewis F. High-dose Anti-snake Venom Versus Low-dose Anti-snake Venom in the Treatment of Poisonous Snake Bites- A Critical Study. J Assn Physicians India 2004;52:14-7.
7. Vijeth SR, Dutta TK, Shahapurkar J. Correlation of Renal Status with Hematologic Profile in Viperine Bite. Am J Trop Med Hyg 1997;56:168-70.
8. Myint L, Warrel DA, Philips RE, Tin Nu S, Tun P, Maung L. Bites By Russell's Viper (Vipera Russelli Siamensis) In Burma: Haemostatic, Vascular and Renal Disturbances and Response to Treatment. Lancet 1985;2:1259-64.
9. Shah PKD, Chittora MD, Shekhawat JS, Khangaroot D, Vyas MM. Role of Heparin in the Management of Snake (Echis-carinatus) Bite Cases. J Assoc Physicians India 1986;34:621-3.
10. Tariang DD, Philip PJ, Alexander G, et al. Randomised Controlled Trial on the Effective Dose of Anti Snake Venom in Cases of Snake Bite With Systemic Envenomation. J Assoc Physicians India 199-47:369-71.
11. Higginbotham RD. Mast Cells and Local Resistance to Russell's Viper Venom. J Immunol 1965;95:867.
12. Reid HA, Chan KE, Theon PC. Prolonged Coagulation Defect (Defibrination Syndrome) In Malayan Viper Bite. Lancet 1963:1:621-6.
13. Oguma Y, Sakuragawa N, Maki M, Nakagawa M, Hasegawa H. Clinical Effect of Low Molecular Weight Heparin (Fragmin) on Dic: A Multi-center Co-operative Study in Japan. Thromb Res 1990;59:37-49.